Journey to Narayama: Cultural Complexities, Psychedelics and Dementia
AJOB Neuroscience April 3, 2023 R. Ozeki-Hayashi, D. Wilkinson
This commentary argues that ethical discussions about using psychedelics to treat Alzheimer's disease must consider cultural context, not just Western bioethics. Drawing on Japanese experience, the authors identify cultural factors that could make such research more challenging, as well as other factors that might be more accommodating and could even reduce some ethical concerns raised by Peterson et al.